换一批
换一批On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.
作者：
Tao,Jiang [1]
;
Jianhua,Chen [2]
;
Xingxiang,Xu [3]
;
Ying,Cheng [4]
;
Gongyan,Chen [5]
;
Yueyin,Pan [6]
;
Yong,Fang [7]
;
Qiming,Wang [8]
;
Yunchao,Huang [9]
;
Wenxiu,Yao [10]
;
Rui,Wang [11]
;
Xingya,Li [12]
;
Wei,Zhang [13]
;
Yanjun,Zhang [14]
;
Sheng,Hu [15]
;
Renhua,Guo [16]
;
Jianhua,Shi [17]
;
Zhiwu,Wang [18]
;
Peiguo,Cao [19]
;
Donglin,Wang [20]
;
Jian,Fang [21]
;
Hui,Luo [22]
;
Yi,Geng [23]
;
Chunyan,Xing [24]
;
Dongqing,Lv [25]
;
Yiping,Zhang [26]
;
Junyan,Yu [27]
;
Shundong,Cang [28]
;
Yaxi,Zhang [29]
;
Jiao,Zhang [29]
;
Zeyu,Yang [30]
;
Wei,Shi [30]
;
Jianjun,Zou [30]
;
Caicun,Zhou [31]
;
Shengxiang,Ren [32]
作者单位：
Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, No.507, Zhengmin Road, Shanghai, 200433, China.
[1]
Hunan Cancer Hospital, Changsha, China.
[2]
Northern Jiangsu People's Hospital, Yangzhou, China.
[3]
Jilin Cancer Hospital, Changchun, China.
[4]
Harbin Medical University Cancer Hospital, Harbin, China.
[5]
Anhui Provincial Hospital, Hefei, China.
[6]
Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, China.
[7]
Henan Cancer Hospital, Zhengzhou, China.
[8]
Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Centre, Kunming, China.
[9]
Sichuan Provincial Cancer Hospital, Chengdu, China.
[10]
Anhui Chest Hospital, Hefei, China.
[11]
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
[12]
The First Affiliated Hospital of Nanchang University, Nanchang, China.
[13]
Shaanxi Provincial Cancer Hospital, Xi'an, China.
[14]
Hubei Cancer Hospital, Wuhan, China.
[15]
Jiangsu Province Hospital, Nanjing, China.
[16]
LinYi Cancer Hospital, Linyi, China.
[17]
Tangshan People's Hospital, Tangshan, China.
[18]
The Third Xiangya Hospital of Central South University, Changsha, China.
[19]
Chongqing University Cancer Hospital, Chongqing, China.
[20]
Beijing Cancer Hospital, Beijing, China.
[21]
Jiangxi Cancer Hospital, Nanchang, China.
[22]
Baoji Central Hospital, Baoji, China.
[23]
Jinan Central Hospital, Jinan, China.
[24]
Taizhou Hospital of Zhejiang Province, Taizhou, China.
[25]
Zhejiang Cancer Hospital, Hangzhou, China.
[26]
Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.
[27]
Henan Provincial People's Hospital, Zhengzhou, China.
[28]
Genecast Biotechnology Co., Ltd., Wuxi City, China.
[29]
Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
[30]
Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, No.507, Zhengmin Road, Shanghai, 200433, China. caicunzhou_dr@163.com.
[31]
Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, No.507, Zhengmin Road, Shanghai, 200433, China. harry_ren@126.com.
[32]
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 鳞状细胞(Carcinoma, Squamous Cell);综合疗法(Combined Modality Therapy);计算生物学(Computational Biology);DNA, 肿瘤(DNA, Neoplasm);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);分子靶向治疗(Molecular Targeted Therapy);突变(Mutation);肿瘤分期(Neoplasm Staging);预后(Prognosis);治疗结果(Treatment Outcome)
DOI
10.1186/s12943-021-01479-4
PMID
34980131
发布时间
2022-03-28
- 浏览0
Molecular cancer
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
